retatrutide expanded access program Lilly's Retatrutide Availability & Timeline |

Baseline investigations should be guided by clinical indication and comorbidities

Diabetes management: can be used to improve blood sugar control in patients with type 2 diabetes

Studies indicate that 25 to 40 percent of weight lost on GLP-1 agonists can be lean mass, including muscle tissue

YOUR METABOLISM

Reviewed by: Regentide Research Team Last Updated: June 2026 COA Available USA Fulfillment Research Use Only Retatrutide 20mg Research Compound Overview Retatrutide is a synthetic investigational peptide studied for its interaction with multiple receptor systems, including GLP-1, GIP, and glucagon receptor pathways

V draw = D anchor V water M anchor Standard skincare: 2 mg GHK-Cu gives a 10-unit draw V draw = 2 mg 2.5 mL50 mg= 0.1 mL = 10 units Different vial or dose Enter the actual vial ratio and GHK-Cu target in the GLOW calculator